Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: Results from an international, multicenter, randomized pilot study (SWITCH III).

Authors

Ron Waksman, MedStar Washington Hospital Center
Olivier Bertrand, Laval Hospital, Quebec Heart and Lung Institute, QC, Canada
Mitchell Driesman, Bridgeport Hospital, Bridgeport, CT
Luis Gruberg, Stony Brook University
Joseph Rossi, University of North Carolina at Chapel Hill
Shamir Mehta, Hamilton General Hospital, ON, Canada
Stacy Swymelar, MedStar Washington Hospital Center
Danny Dvir, MedStar Washington Hospital Center
Zhenyi Xue, MedStar Washington Hospital CenterFollow

Document Type

Journal Article

Publication Date

4-2013

Journal

Journal of Interventional Cardiology

Volume

Volume 26, Issue 2

Inclusive Pages

107-113

APA Citation

Waksman, R., Bertrand, O., Driesman, M., Gruberg, L., Rossi, J., Mehta, S., . . . Torguson, R. (2013). Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-st-segment elevation acute coronary syndrome initially treated with fondaparinux: Results from an international, multicenter, randomized pilot study (SWITCH III). Journal of Interventional Cardiology, 26(2), 107-113.

Peer Reviewed

1